ARCHIVES

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

Intramural AIDS Vaccine Research Center In Development By NCI, NIAID Scientists

June 13, 1997

In Brief: Lane Adams Retires, Gadberry New Executive VP; Lemaistre ACS President, Loeb President Elect

November 15, 1985

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994